Condition: Adult Congenital Heart Disease · Congenital Heart Disease · Systemic Right Ventricle · Sponsor: Leiden University Medical Center
This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease (ACHD) patients by investigating the prescription patterns, safety, tolerability, and potential beneficial effects on heart failure-related outcomes.
This description comes directly from the study's public registry record.
Ralph M.L. Neijenhuis, MD · +31 71 5262020 · r.m.l.neijenhuis@lumc.nl
Björn N. Westdorp, MD · +31 71 5262020 · b.n.westdorp@lumc.nl
Always discuss trial participation with your own doctor first.
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
| Helen DeVos Children's Hospital | Grand Rapids, Michigan, United States | Recruiting |
| Mount Sinai Fuster Heart Hospital | New York, New York, United States | Recruiting |
| Heart Center Duisburg (Evangelical Hospital Niederrhein) | Duisburg, Germany | Recruiting |
| Leiden University Medical Center (LUMC) | Leiden, South Holland, Netherlands | Recruiting |
| Amsterdam University Medical Center | Amsterdam, Netherlands | Recruiting |
| University Medical Center Utrecht | Utrecht, Netherlands | Recruiting |
| Zan Mitrev Clinic | Skopje, North Macedonia | Recruiting |
| University Hospital of Wales | Cardiff, United Kingdom | Recruiting |
| Golden Jubilee University National Hospital | Glasgow, United Kingdom | Recruiting |
| Barts Heart Centre | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06932081